CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
Lymphoma is a cancer of the lymph nodes and lymphatic system. The two main types are Hodgkin and non-Hodgkin. Non-Hodgkin is the most common. The main symptom is usually an enlargement of lymph nodes that does not go away as it normally would after infection. There is no way to prevent lymphoma, but survival rates after treatment are good.